Page 14 - Read Online
P. 14

Page 10               Fracaro et al. Neuroimmunol Neuroinflammation 2020;7:1-12  I  http://dx.doi.org/10.20517/2347-8659.2019.009

               Copyright
               © The Author(s) 2020.


               REFERENCES
               1.   Karaoz E, Kabatas S, Duruksu G, Okcu A, Subasi C, et al. Reduction of lesion in injured rat spinal cord and partial functional recovery
                   of motility after bone marrow derived mesenchymal stem cell transplantation. Turk Neurosurg 2012;22:207-17.
               2.   Yi XM, Chen Y, Tu GJ. Neuregulin-1 impacting bone marrow mesenchymal stem cell migration is conducive to functional recovery
                   following spinal cord injury. Mol Med Rep 2019;20:41-8.
               3.   Jain NB, Ayers GD, Peterson EN, Harris MB, Morse L, et al. Traumatic spinal cord injury in the United States, 1993-2012. Jama
                   2015;313:2236-43.
               4.   Center NSCIS. Facts and Figures at a Glance. University of Alabama at Birmingham 2018.
               5.   Shende P, Subedi M. Pathophysiology, mechanisms and applications of mesenchymal stem cells for the treatment of spinal cord injury.
                   Biomed Pharmacother 2017;91:693-706.
               6.   Ahuja CS, Nori S, Tetreault L, Wilson J, Kwon B, et al. Traumatic spinal cord injury-repair and regeneration. Neurosurgery
                   2017;80:S9-22.
               7.   Kjell J, Olson L. Rat models of spinal cord injury: from pathology to potential therapies. Dis Model Mech 2016;9:1125-37.
               8.   Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, et al. The cellular inflammatory response in human spinal cords
                   after injury. Brain 2006;129:3249-69.
               9.   Beattie MS. Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol Med 2004;10:580-3.
               10.  Okada S. The pathophysiological role of acute inflammation after spinal cord injury. Inflamm Regen 2016;36:20.
               11.  Rust R, Kaiser J. Insights into the dual role of inflammation after spinal cord injury. J Neurosci 2017;37:4658-60.
               12.  Liu J, Yang X, Jiang L, Wang C, Yang M. Neural plasticity after spinal cord injury. Neural Regene Res 2012;7:386-91.
               13.  Darian-Smith C. Synaptic plasticity, neurogenesis, and functional recovery after spinal cord injury. Neuroscientist 2009;15:149-65.
               14.  Qu J, Zhang H. Roles of mesenchymal stem cells in spinal cord injury. Stem Cells Int 2017;2017:5251313.
               15.  Ahuja CS, Martin AR, Fehlings M. Recent advances in managing a spinal cord injury secondary to trauma. F1000Res 2016;5.
               16.  Rouanet C, Reges D, Rocha E, Gagliardi V, Silva GS. Traumatic spinal cord injury: current concepts and treatment update. Arq
                   Neuropsiquiatr 2017;75:387-93.
               17.  Fehlings MG, Vaccaro A, Wilson JR, Singh A, W Cadotte D, et al. Early versus delayed decompression for traumatic cervical spinal
                   cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS). PLoS One 2012;7:e32037.
               18.  Sewell MD, Vachhani K, Alrawi A, Williams R. Results of early and late surgical decompression and stabilization for acute traumatic
                   cervical spinal cord injury in patients with concomitant chest injuries. World Neurosurg 2018;118:e161-5.
               19.  Wilson JR, Forgione N, Fehlings MG. Emerging therapies for acute traumatic spinal cord injury. CMAJ 2013;185:485-92.
               20.  Hall ED, Springer JE. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 2004;1:80-100.
               21.  Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, et al. Administration of methylprednisolone for 24 or 48 hours
                   or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury
                   Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997;277:1597-604.
               22.  Schapira AHV. Chapter 18 - Neuroprotection in Parkinson’s Disease. In: Schapira AHV, Samuels MA, editors. Blue Books of
                   Neurology: Butterworth-Heinemann; 2010. pp. 301-20.
               23.  Casha S, Zygun D, McGowan MD, Bains I, Yong VW, et al. Results of a phase II placebo-controlled randomized trial of minocycline
                   in acute spinal cord injury. Brain 2012;135:1224-36.
               24.  Ulndreaj A, Badner A, Fehlings MG. Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the
                   differential effects among anatomical levels of injury. F1000Res 2017;6:1907.
               25.  Wang J, Pearse DD. Therapeutic hypothermia in spinal cord injury: the status of its use and open questions. Int J Mol Sci
                   2015;16:16848-79.
               26.  Levi AD, Green BA, Wang MY, Dietrich WD, Brindle T, et al. Clinical application of modest hypothermia after spinal cord injury. J
                   Neurotrauma 2009;26:407-15.
               27.  Grossman RG, Fehlings MG, Frankowski RF, Burau KD, Chow DS, et al. A prospective, multicenter, phase I matched-comparison
                   group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. J
                   Neurotrauma 2014;31:239-55.
               28.  Mu X, Azbill RD, Springer JE. Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal
                   cord injury. J Neurotrauma 2000;17:773-80.
               29.  Chen XM, Xu J, Song JG, Zheng BJ, Wang XR. Electroacupuncture inhibits excessive interferon-gamma evoked up-regulation of
                   P2X4 receptor in spinal microglia in a CCI rat model for neuropathic pain. Br J Anaesth 2015;114:150-7.
               30.  Zhang YT, Jin H, Wang JH, Wen LY, Yang Y, et al. Tail nerve electrical stimulation and electro-acupuncture can protect spinal motor
                   neurons and alleviate muscle atrophy after spinal cord transection in rats. Neural plasticity 2017;2017:7351238.
               31.  Chen W, Wu Y. Electro-acupuncture (EA) mediated downregulation of microRNA-181a alleviates spinal cord neuronal apoptosisby
                   inhibition of p38 MAPK pathway. Int J Clin Exp Med 2017;10:7806-15.
               32.  Krueger E, Magri LMS, Botelho AS, Bach FS, Rebellato CLK, et al. Effects of low-intensity electrical stimulation and adipose derived
                   stem cells transplantation on the time-domain analysis-based electromyographic signals in dogs with SCI. Neurosci Lett 2019;696:38-45.
               33.  Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007;213:341-7.
               34.  Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol 2009;217:318-24.
               35.  Scuteri A, Miloso M, Foudah D, Orciani M, Cavaletti G, et al. Mesenchymal stem cells neuronal differentiation ability: a real
   9   10   11   12   13   14   15   16   17   18   19